Manulife (Manufacturers Life Insurance)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Sell |
146,952
-281,823
| -66% | -$10.2M | ﹤0.01% | 1136 |
|
|
2025
Q1 | $13.3M | Buy |
428,775
+276,821
| +182% | +$8.62M | 0.01% | 722 |
|
|
2024
Q4 | $3.88M | Sell |
151,954
-73
| -0% | -$1.86K | ﹤0.01% | 1304 |
|
|
2024
Q3 | $4.3M | Sell |
152,027
-127,825
| -46% | -$3.62M | ﹤0.01% | 1268 |
|
|
2024
Q2 | $7.38M | Sell |
279,852
-2,934,926
| -91% | -$77.4M | 0.01% | 971 |
|
|
2024
Q1 | $97.6M | Buy |
3,214,778
+2,660,773
| +480% | +$80.8M | 0.09% | 212 |
|
|
2023
Q4 | $15.6M | Buy |
554,005
+196,775
| +55% | +$5.53M | 0.01% | 694 |
|
|
2023
Q3 | $9.7M | Sell |
357,230
-2,133,184
| -86% | -$57.9M | 0.01% | 827 |
|
|
2023
Q2 | $76.6M | Sell |
2,490,414
-288,246
| -10% | -$8.86M | 0.04% | 249 |
|
|
2023
Q1 | $100M | Buy |
2,778,660
+782,223
| +39% | +$28.2M | 0.06% | 217 |
|
|
2022
Q4 | $78.9M | Sell |
1,996,437
-395,420
| -17% | -$15.6M | 0.05% | 241 |
|
|
2022
Q3 | $96.1M | Buy |
2,391,857
+2,176,904
| +1,013% | +$87.5M | 0.07% | 199 |
|
|
2022
Q2 | $9.04M | Buy |
214,953
+42,715
| +25% | +$1.8M | 0.01% | 854 |
|
|
2022
Q1 | $6.72M | Buy |
172,238
+161,857
| +1,559% | +$6.31M | ﹤0.01% | 1038 |
|
|
2021
Q4 | $414 | Hold |
10,381
| – | – | ﹤0.01% | 2392 |
|
|
2021
Q3 | $375K | Sell |
10,381
-124,400
| -92% | -$4.49M | ﹤0.01% | 2498 |
|
|
2021
Q2 | $5.53M | Sell |
134,781
-58,608
| -30% | -$2.4M | ﹤0.01% | 1238 |
|
|
2021
Q1 | $8.44M | Sell |
193,389
-13,966
| -7% | -$609K | 0.01% | 1022 |
|
|
2020
Q4 | $10.4M | Buy |
207,355
+22,734
| +12% | +$1.14M | 0.01% | 872 |
|
|
2020
Q3 | $7.77M | Sell |
184,621
-31,524
| -15% | -$1.33M | 0.01% | 909 |
|
|
2020
Q2 | $9.49M | Buy |
+216,145
| New | +$9.49M | 0.01% | 797 |
|